Senescent cells linked to poor insulin release in human islets
Analyses of donated human islets identified an insulin-producing cell population that emerged early in type 2 diabetes and showed signs of senescence.
Limit: The experiments measured beta cell function, not diabetes treatment outcomes
Stake: Prodo Laboratories funded the study.
Edited by Boris Djordjevic · AgingResearch.News
Human pancreatic islets—clusters containing insulin-producing beta cells—were studied through observational analyses of donor samples, alongside experiments in isolated islets and mice. Researchers identified senescence, a stress response in which cells permanently stop dividing, in beta cells expressing p21, a protein that halts cell division. This population emerged early in type 2 diabetes. In human donor islets, higher p21 levels were linked to poorer insulin release.
In experiments with mouse cells, substances released by senescent beta cells induced senescence and dysfunction in neighboring cells. Drugs that inhibit Janus kinases, proteins involved in cell signaling, counteracted this process. In mice fed a high-fat diet, they restored responsiveness to glucose, a sugar.
Why it matters
For research on cell senescence, the findings raise the question of whether targeting signals released by these cells could preserve insulin-producing cell function in type 2 diabetes.
Caveats
The human donor associations do not establish causation. Drug effects in isolated human islets and mice do not establish that these drugs treat diabetes in people.
